US Stock MarketDetailed Quotes

IMCR Immunocore

Watchlist
  • 30.220
  • +1.560+5.44%
Close Dec 26 16:00 ET
  • 29.480
  • -0.740-2.45%
Post 16:59 ET
1.51BMarket Cap-31.81P/E (TTM)

Immunocore Key Stats

Immunocore Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 69.221M--
--2024/Q4-- / 67.069M--
--2024/Q361.695M / 62.640M--
Aug 8, 20242024/Q259.260M / 58.791M--
--2024/Q170.502M / 55.236M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 69.221M--
--2024/Q4-- / 67.069M--
--2024/Q361.695M / 62.640M--
Aug 8, 20242024/Q259.260M / 58.791M--
--2024/Q170.502M / 55.236M--

Unlock Free Earnings Estimates

Immunocore Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 20, 2024

Buy

  • Buy

    71.43%
  • Hold

    21.43%
  • Sell

    7.14%

Price Target

No Data